Corneal Endothelium Cell Loss After Cataract Extraction in Patients Taking Tamsulosin
NCT ID: NCT01076309
Last Updated: 2011-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2009-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule
NCT03855293
The Effect of Anterior Corneal Incisions on Intraoperative Floppy Iris Syndrome (IFIS) Incidence and Severity in Tamsulosin Treated Cataract Patients
NCT01070602
Ultrasonic System for Cataract Characterization and Optimal Phacoemulsification Energy Evaluation
NCT04461912
Outcomes of Phacoemulsification With Torsional Ultrasound
NCT01010490
Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome
NCT06266962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cornea is examined by specular microscopy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tamsulosin
Patients taking tamsulosin
No interventions assigned to this group
Non-tamsulosin
Patients not taking tamsulosin.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* corneal scarring
* diabetes
* uveitis
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Frederiksberg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederiksberg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frederiksberg University Hospital
Frederiksberg, Frederiksberg, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FH4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.